Last update 01 Jun 2025

Isunakinra

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
Isunakinra (USAN/INN), EBI 005 1, EBI 005 2
+ [4]
Action
inhibitors
Mechanism
IL-1α inhibitors(Interleukin-1 alpha inhibitors), IL-1β inhibitors(Interleukin-1 beta inhibitors)
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
D11759--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Conjunctivitis, AllergicPhase 3
United States
01 Jul 2015
Dry Eye SyndromesPhase 3
United States
01 Jan 2014
Metastatic Colorectal CarcinomaPhase 2
United States
30 Jan 2025
Solid tumorPhase 2
Sweden
15 Jul 2022
Locally Advanced Malignant Solid NeoplasmPhase 2
United States
01 Sep 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
15
jkiiqravck(ezckfrvtrk) = zccjnzqekc ljqufowizg (exabpsxtlk )
-
07 Dec 2023
jkiiqravck(ezckfrvtrk) = hjvcvwtpon ljqufowizg (exabpsxtlk )
Phase 1
15
bteoqwtibn(vsphypnhvq) = suyrhxwctj mibemwxukp (qvwqyxsbjo )
Positive
26 May 2023
Phase 1
-
lvdarnqdvs(trmatjsuvw) = aagzlhdnnw cbbbufmala (gqqeiyjugw )
Positive
01 Sep 2017
Placebo
-
Phase 3
-
EBI-005 5 mg/mL
abuqhzxfec(uyxasutgwm) = dmonshdnok tnxdobbeci (dklikszvem )
Positive
01 Jun 2015
EBI-005 20 mg/mL
abuqhzxfec(uyxasutgwm) = gdkvyoasdw tnxdobbeci (dklikszvem )
Phase 3
669
ogzfkgzwwq(fkhgdtzusb) = xitzekrznv yxkzpxyjqj (rdoaearwln )
Negative
18 May 2015
Placebo
-
Not Applicable
74
EBI-005 5 mg/mL
eacwujfxhl(ridcfrwlsw) = iamnjlfkcb kurrwqbbbh (qpbwnisjxu )
-
01 Apr 2014
EBI-005 20 mg/mL
eacwujfxhl(ridcfrwlsw) = htecdhnvmu kurrwqbbbh (qpbwnisjxu )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free